Overview

A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the single-dose pharmacokinetics (PK) of AB521 tablet versus the AB521 capsule, and to evaluate the effect of food on the single-dose PK of AB521 tablet in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Arcus Biosciences, Inc.